Brett P. Monia, Chief Executive Officer at IONIS PHARMACEUTICALS INC (IONS), sold 437 shares at $69.26 ($30K) on 2025-10-06, disclosed to the SEC on 2025-10-08.
Scheduled sale ($30k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2026-03-11 | $24.2M | — | Filing → |
| IONS | SELL | 2026-02-10 | $2.5M | — | Filing → |
| IONS | SELL | 2026-02-02 | $5.2M | — | Filing → |